COVID-19 adverse outcome pathway
Pathways in the COVID-19 adverse outcome pathway SuperPath
| # | Name | Source | Genes |
|---|---|---|---|
| 1 | COVID-19 adverse outcome pathway | WikiPathways |
Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways
| # | Symbol | Description | Category | # Related Pathways |
|---|---|---|---|---|
| 1 | TMPRSS2 | Transmembrane Serine Protease 2 | Protein Coding | 1 |
| 2 | CCL3 | C-C Motif Chemokine Ligand 3 | Protein Coding | 1 |
| 3 | CCL2 | C-C Motif Chemokine Ligand 2 | Protein Coding | 1 |
| 4 | ACE2 | Angiotensin Converting Enzyme 2 | Protein Coding | 1 |
| 5 | CXCL10 | C-X-C Motif Chemokine Ligand 10 | Protein Coding | 1 |
| 6 | CXCL8 | C-X-C Motif Chemokine Ligand 8 | Protein Coding | 1 |
| 7 | IL6 | Interleukin 6 | Protein Coding | 1 |
| 8 | IL2RA | Interleukin 2 Receptor Subunit Alpha | Protein Coding | 1 |
| 9 | IL2 | Interleukin 2 | Protein Coding | 1 |
| 10 | AGT | Angiotensinogen | Protein Coding | 1 |
Disorders associated with COVID-19 adverse outcome pathway SuperPath
according to GeneCards Suite gene sharing
| # | Disorder | Type | Genes | Score |
|---|---|---|---|---|
| 1 | Human immunodeficiency virus type 1 | Enrichment | CCL2, CCL3 | 4.13 |
| 2 | Type 1 diabetes mellitus 10 | Enrichment | IL2RA | 3.13 |
| 3 | Immunodeficiency 41 with lymphoproliferation and autoimmunity | Enrichment | IL2RA | 2.83 |
| 4 | Kaposi sarcoma | Enrichment | IL6 | 2.53 |
| 5 | Systemic-onset juvenile idiopathic arthritis | Enrichment | IL6 | 2.53 |
| 6 | Rheumatoid arthritis, systemic juvenile | Enrichment | IL6 | 2.43 |
| 7 | Type 1 diabetes mellitus | Enrichment | IL6 | 2.35 |
| 8 | Renal tubular dysgenesis | Enrichment | AGT | 2.35 |
| 9 | Oligoarticular juvenile idiopathic arthritis | Enrichment | IL2RA | 2.29 |
| 10 | Rheumatoid factor-negative juvenile idiopathic arthritis | Enrichment | IL2RA | 2.29 |
| 11 | Inflammatory bowel disease 1 | Enrichment | IL6 | 2.18 |
| 12 | Hypertension, essential | Enrichment | AGT | 1.90 |
| 13 | Arteriovenous malformations of the brain | Enrichment | IL6 | 1.86 |
| 14 | Type 2 diabetes mellitus | Enrichment | IL6 | 1.52 |
| 15 | Breast cancer | Enrichment | IL2 | 1.27 |